Boston Scientific Corp (BSX)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$92.03
Buy
$92.47
$-0.39 (-0.42%)
Prices updated at 15 Dec 2025, 13:56 EST
| Prices minimum 15 mins delay
Prices in USD
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 68.61 |
| 2023 | 69.49 |
| 2022 | 68.81 |
| 2021 | 68.78 |
| 2020 | 64.59 |
| 2019 | 70.37 |
| 2018 | 70.65 |
| 2017 | 70.59 |
| 2016 | 70.15 |
| 2015 | 70.00 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 7.11 |
| 2024 | 8.32 |
| 2023 | 6.11 |
| 2022 | 5.29 |
| 2021 | 5.30 |
| 2020 | 5.03 |
| 2019 | 6.13 |
| 2018 | 5.11 |
| 2017 | 3.90 |
| 2016 | 3.62 |
| 2015 | 3.34 |
Price/Forward earnings (YTD)
26.67
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | 4.97 |
| 2023 | 4.64 |
| 2022 | 1.98 |
| 2021 | 3.13 |
| 2020 | -0.37 |
| 2019 | 18.23 |
| 2018 | 8.35 |
| 2017 | 0.56 |
| 2016 | 1.92 |
| 2015 | -1.36 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 1.81 |
| 2023 | 1.82 |
| 2022 | 1.85 |
| 2021 | 1.94 |
| 2020 | 2.01 |
| 2019 | 2.20 |
| 2018 | 2.41 |
| 2017 | 2.72 |
| 2016 | 2.69 |
| 2015 | 2.87 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
